Form D · Pharmaceuticals
MEDRACON, INC.
Oak Brook, IL · CIK 0001473377
Offering snapshot reported Oct 8, 2009 · SEC filing
- Reported sold
- Yet to sell Offering amount: $6M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2009 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $600K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- Not reported
The Company has not yet retained any broker-dealers, but expects to do so and to pay commissions of up to ten percent of sales.
Source: Form D, filed Oct 8, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Coles | Executive |
| Arlene Corris Coles | Executive |
| Frank L Jaksch | Director, Executive |
| Min Li | Director |
| Edward Ma | Director, Executive |
| Thomas Varvaro | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1415 West 22 Nd Street Tower Floor
Oak Brook, IL, 60523
Oak Brook, IL, 60523